Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 704 participants.

Also called NCT04523220

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 704 participants (enrolled count) (from the registry)
Sponsor
  • Bayer Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04523220
  • EudraCT 2019-003957-27
Other papers using this trial's data
  • Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial Nature medicine, 2024-02 DOI, PubMed 38365952, PMC10878964 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Austria, Belgium, Bulgaria, Czechia, Greece, Hungary, Israel, Italy, Japan, Lithuania, Netherlands, Poland, Portugal, Russia, Spain, Türkiye, Ukraine (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04523220. Randomized; triple masking; primary purpose treatment. Start 2020-08-28 (actual); primary completion 2021-12-28 (actual). Results posted on 2023-07-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis
Acronym
CONVERT
Condition
End-stage Renal Disease
Condition
Prevention of Thromboembolic Events
Condition
Hemodialysis
Condition
Hemodiafiltration
Intervention (Drug)
BAY1213790 (Osocimab)
Intervention (Drug)
Placebo
Lead sponsor
Bayer (class: industry)

Record details

Record id
cardio:ct-nct04523220
Content hash
891566af7be6cb095c91d4d58deb80a5329a13569525c5e180924a3d894244fe